Copyright
©The Author(s) 2021.
World J Gastroenterol. May 14, 2021; 27(18): 2131-2140
Published online May 14, 2021. doi: 10.3748/wjg.v27.i18.2131
Published online May 14, 2021. doi: 10.3748/wjg.v27.i18.2131
Table 1 Recommended management and evidence level in current guidelines for asymptomatic common bile duct stones
Guideline | Recommendation |
ESGE[1] | ESGE recommends stone extraction in all patients with CBDS, regardless of being symptomatic or not, who are fit enough to tolerate the intervention. (Strong recommendation, low quality evidence) |
BSG[3] | Stone extraction is recommended in patients diagnosed with CBDS if possible. Evidence of benefit of stone extraction is greatest for symptomatic patients (Low quality evidence; strong recommendation) |
JGES[4] | Asymptomatic choledocholithiasis should be treated because of a risk of developing biliary complications. [Evidence level: A; Strength of recommendation (agreement rate): 2 (100%)] |
ASGE[5] | CBDS should be treated if detected regardless of the presence or absence of significant mitigating clinical circumstances (Moderate quality) |
- Citation: Saito H, Kadono Y, Shono T, Kamikawa K, Urata A, Nasu J, Imamura H, Matsushita I, Tada S. Remaining issues of recommended management in current guidelines for asymptomatic common bile duct stones. World J Gastroenterol 2021; 27(18): 2131-2140
- URL: https://www.wjgnet.com/1007-9327/full/v27/i18/2131.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i18.2131